R
Raymond R. Townsend
Researcher at University of Pennsylvania
Publications - 706
Citations - 47086
Raymond R. Townsend is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Blood pressure & Kidney disease. The author has an hindex of 84, co-authored 673 publications receiving 39096 citations. Previous affiliations of Raymond R. Townsend include University of Texas Medical Branch & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Central blood pressure measurements - An opportunity for efficacy and safety in drug development?
Raymond R. Townsend,Mary J. Roman,Samer S. Najjar,John R. Cockcroft,Peter U. Feig,Norman Stockbridge +5 more
TL;DR: This commentary is a summary of a one-day meeting with the FDA in which the role of central blood pressure measurements as an adjunct to drug efficacy and safety were addressed.
Journal ArticleDOI
A study of the VaSera arterial stiffness device in US patients.
TL;DR: This study studied 20 male and 28 female volunteers without reported cardiovascular or renal disease and no history of smoking to begin the process of collecting normal values in the United States, supporting recent findings from meta‐analyses and studies but contradicting other work.
Journal ArticleDOI
Blood pressure in patients with atrial fibrillation: part 2—treatment
Journal ArticleDOI
Human urotensin II in the plasma of anephric subjects.
Journal ArticleDOI
Lifestyle Modification in Blood Pressure Study II (LIMBS): Study protocol of a randomized controlled trial assessing the efficacy of a 24 week structured yoga program versus lifestyle modification on blood pressure reduction
Debbie L. Cohen,Annie Bowler,Stephen A. Fisher,Angela Norris,Andrew B. Newberg,Hengyi Rao,Rupal Bhavsar,John A. Detre,Thomas Tenhave,Raymond R. Townsend +9 more
TL;DR: The LIMBS study will determine if yoga therapy combined with enhanced lifestyle modification will result in clinically meaningful decreases in blood pressure and thus can be implemented as an alternative to drug therapy for patients with prehypertension and stage 1 hypertension.